SARAH BROUGHTON: Open Payments
NPI 1740720465 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,777 in 143 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $4,474 · 2025 $3,777
Food & beverage: $3,693Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $1,147 |
| Janssen Biotech, Inc. | 16 | $495 |
| Lilly USA, LLC | 16 | $430 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $308 |
| Madrigal Pharmaceuticals | 9 | $306 |
| QOL Medical, LLC | 6 | $164 |
| Ardelyx, Inc. | 6 | $147 |
| Regeneron Healthcare Solutions, Inc. | 5 | $143 |
| Intercept Pharmaceuticals, Inc. | 6 | $115 |
| Celltrion USA Inc. | 6 | $115 |
Products named: TREMFYA, OMVOH, RINVOQ, REZDIFFRA, ENTYVIO, CREON, DUPIXENT, SKYRIZI.
Industry payments across MO — which companies pay providers there.
